β-Amyloid1–42 Binds to α7 Nicotinic Acetylcholine Receptor with High Affinity
By Hoau Yan Wang, D. Lee, M. D'Andrea, P. A. Peterson, R. Shank, A. Reitz. Journal of Biological Chemistry, 2000
682 citations recorded by the source corpus.
Alzheimer's disease pathology is characterized by the presence of neuritic plaques and the loss of cholinergic neurons in the brain. The underlying mechanisms leading to these events are unclear, but the 42-amino acid β-amyloid peptide (Aβ1–42) is involved. Immunohistochemical studies on human sporadic Alzheimer's disease brains demonstrate that Aβ1–42 and a neuronal pentameric cation channel, the α7 nicotinic acetylcholine receptor (α7nAChR), are both present in neuritic plaques and co-localize in individual cortical neurons. Using human brain tissues and cells that overexpress either α7nAChR or amyloid precursor protein as the starting material, Aβ1–42 and α7nAChR can be co-immunoprecipitated by the respective specific antibodies, suggesting that they are tightly associated. The formation of the α7nAChR·Aβ1–42complex can be efficiently suppressed by Aβ12–28, implying that this Aβ sequence region contains the binding epitope. Receptor binding experiments show that Aβ1–42 and α7nAChR bind with high affinity, and this interaction can be inhibited by α7nAChR ligands. Human neuroblastoma cells overexpressing α7nAChR are readily killed by Aβ1–42, whereas α7nAChR agonists such as nicotine and epibatidine offered protection. Because Aβ1–42 inhibits α7nAChR-dependent calcium activation and acetylcholine release, two processes critically involved in memory and cognitive functions, and the distribution of α7nAChR correlates with neuritic plaques in Alzheimer's disease brains, we propose that interaction of the α7nAChR and Aβ1–42 is a pivotal mechanism involved in the pathophysiology of Alzheimer's disease.
Subfields: Molecular Biology, Pharmacology, Physiology
View Paper: https://www.semanticscholar.org/paper/5adb70655d8203e9d4d86d7f97ea399083dd2b7d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
In Pharmacology
In Physiology
Citations in the corpus
- Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology (2001, background): “We have examined several postulated mechanisms of AbP toxicity, including 1) its interaction with plasma membrane receptors such as tachykinin receptors (26), NMDA receptors (28), or nAChR ( 27 ) and 2) changing cellular ionic concentration by modulating the activity of preexisting channels (49) or ”
- Ultrastructural Distribution of the α7 Nicotinic Acetylcholine Receptor Subunit in Rat Hippocampus (2001, background): “Finally, the near-ubiquitous presence of 7 nAChRs at hippocampal synapses described here renders more salient the recent report (Wang et al., 2000b) of high-affinity binding of -amyloid peptide (A 1–42) to 7 nAChRs.”
- Picomolar amyloid-β positively modulates synaptic plasticity and memory in hippocampus (2008, result): “This model is consistent with the observation that A 42 might bind selectively and with picomolar affinity to 7-nAChRs (Wang et al., 2000), or it might be responsible for regulation of nAChR function through strong binding with membrane lipids (Small et al., 2007).”
- Regulation of NMDA receptor trafficking by amyloid-β (2005, background): “Role of α-7 nicotinic receptor and protein phosphatase 2B Amyloid-β binds to the α-7 nicotinic receptor with picomolar affinit”
- The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade (2018, background): “receptor (p75NTR) [210], alpha7-nicotinic acetylcholine receptor ( 7nAChR) [211, 212], adrenergic receptors [213], the receptor for advanced glycation endproducts (RAGE) [214], calcium channels [215–217], leukocyte immunoglobulin-like receptor subfamily B member 2 (LILRB2)/paired Ig-like receptor B ”
- Furin at the cutting edge: From protein traffic to embryogenesis and disease (2002, neutral): “gov/htbin-post/Omim/dispmim?104300#DESCRIPTION">Alzheimer's disease”